FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4231010012> ?p ?o ?g. }

• W4231010012 endingPage "2487" @default.
• W4231010012 startingPage "2487" @default.
• W4231010012 abstract "Abstract Abstract 2487 Introduction: Despite significant advances in the understanding of the biology of adult acute myelogenous leukemia (AML), overall survival remains poor due chiefly to the high rate of relapse after achieving complete remission as well as primary failure of induction chemotherapy. Efforts to further unravel the mechanisms leading to relapse and primary refractory disease are critical in order to guide the development of effective and durable treatment strategies for AML. To that end, this study seeks to elucidate the clonal relationship of AML in various disease phases. Methods: We employed SNP 6.0 array-based genomic profiling of acquired copy number aberrations (aCNA) and copy neutral LOH (cnLOH) together with sequence analysis of recurrently mutated genes to characterize paired AML genomes. We analyzed 28 AML sample pairs from patients that achieved complete remission with chemotherapy and subsequently relapsed (median remission duration 272 days [range 25 – 1249 days]) and 11 sample pairs from patients with persistent disease following induction chemotherapy. AML cell samples were isolated with a Ficoll gradient, negatively selected using Miltenyi microbead columns, and then further purified with flow cytometric cell sorting. Processed DNA isolated from highly purified AML blasts and paired buccal DNA was hybridized to Affymetrix SNP 6.0 arrays. aCNA were visually identified using the dChip program in paired data displays and corroborated by algorithmic lesion scoring, and cnLOH was detected using internally developed software. In addition, 11 genes known to be recurrently mutated in AML (CEBPA, DNMT3A, IDH1, IDH2, RUNX1, BCORL1, NPM1, NRAS, KRAS, FLT3 and TP53) were resequenced in all 39 presentation samples to identify somatically acquired mutations. Genes found mutated in individual AML cases were subsequently tested for the persistence of the mutation in paired samples. Results: For the 28 paired specimens in the relapsed cohort, comparison of aCNA and cnLOH occurrences, gene mutation patterns and karyotypes revealed 6 cases that carried no aCNA/cnLOH at either presentation or relapse, but at presentation carried at least 1 gene mutation, all of which but one were stable in relapse (1 case lost a RUNX1 mutation but carried a t(8;21) in both disease stages); 11 cases that were characterized by the presence of aCNA/cnLOH at presentation, of which 55% (6 of 11) gained additional aCNA/cnLOH at relapse; 6 cases without aCNA/cnLOH at presentation that gained aCNA/cnLOH at relapse, of which 2 concurrently lost a FLT3-ITD or CEPBA mutation; and 5 cases that carried no informative genomic events. For the 11 paired specimens in the persistent AML cohort, the same comparison revealed 2 cases without aCNA/cnLOH before or after chemotherapy and stable gene mutations; 5 cases with aCNA/cnLOH at presentation that carried the same genomic lesions and gene mutations before and after chemotherapy; 3 cases with aCNA/cnLOH present at enrollment that lost some but not all of these aCNA/cnLOH and gained none after initial induction therapy; and 1 additional case that lost a FLT3-ITD. Comparative analysis of these patterns demonstrates that relapsed AML invariably represents reemergence or evolution of an antecedent clone. Furthermore, all individual aCNA or cnLOH detected at presentation persisted at relapse indicating that this lesion type is proximally involved in AML evolution. Analysis of informative paired persistent AML disease samples uncovered at least two coexisting dominant clones of which at least one was chemotherapy sensitive and one resistant. Conclusion: This detailed genomic analysis supports the conclusion that incomplete eradication of AML founder clones rather than stochastic emergence of fully unrelated novel clones underlies AML relapse and persistence with direct implications for clinical AML research. Disclosures: No relevant conflicts of interest to declare." @default.
• W4231010012 created "2022-05-11" @default.
• W4231010012 creator A5002639476 @default.
• W4231010012 creator A5013706483 @default.
• W4231010012 creator A5022598327 @default.
• W4231010012 creator A5033510515 @default.
• W4231010012 creator A5085769609 @default.
• W4231010012 creator A5086477374 @default.
• W4231010012 date "2012-11-16" @default.
• W4231010012 modified "2023-09-28" @default.
• W4231010012 title "Clonal Evolution and Devolution Following Chemotherapy in Adult Acute Myelogenous Leukemia." @default.
• W4231010012 doi "https://doi.org/10.1182/blood.v120.21.2487.2487" @default.
• W4231010012 hasPublicationYear "2012" @default.
• W4231010012 type Work @default.
• W4231010012 citedByCount "0" @default.
• W4231010012 crossrefType "journal-article" @default.
• W4231010012 hasAuthorship W4231010012A5002639476 @default.
• W4231010012 hasAuthorship W4231010012A5013706483 @default.
• W4231010012 hasAuthorship W4231010012A5022598327 @default.
• W4231010012 hasAuthorship W4231010012A5033510515 @default.
• W4231010012 hasAuthorship W4231010012A5085769609 @default.
• W4231010012 hasAuthorship W4231010012A5086477374 @default.
• W4231010012 hasConcept C104317684 @default.
• W4231010012 hasConcept C122060243 @default.
• W4231010012 hasConcept C135763542 @default.
• W4231010012 hasConcept C143998085 @default.
• W4231010012 hasConcept C153209595 @default.
• W4231010012 hasConcept C203014093 @default.
• W4231010012 hasConcept C21790070 @default.
• W4231010012 hasConcept C2483381 @default.
• W4231010012 hasConcept C2778461978 @default.
• W4231010012 hasConcept C2781187634 @default.
• W4231010012 hasConcept C30481170 @default.
• W4231010012 hasConcept C45091340 @default.
• W4231010012 hasConcept C501734568 @default.
• W4231010012 hasConcept C502942594 @default.
• W4231010012 hasConcept C53226629 @default.
• W4231010012 hasConcept C54355233 @default.
• W4231010012 hasConcept C59701697 @default.
• W4231010012 hasConcept C71924100 @default.
• W4231010012 hasConcept C86803240 @default.
• W4231010012 hasConceptScore W4231010012C104317684 @default.
• W4231010012 hasConceptScore W4231010012C122060243 @default.
• W4231010012 hasConceptScore W4231010012C135763542 @default.
• W4231010012 hasConceptScore W4231010012C143998085 @default.
• W4231010012 hasConceptScore W4231010012C153209595 @default.
• W4231010012 hasConceptScore W4231010012C203014093 @default.
• W4231010012 hasConceptScore W4231010012C21790070 @default.
• W4231010012 hasConceptScore W4231010012C2483381 @default.
• W4231010012 hasConceptScore W4231010012C2778461978 @default.
• W4231010012 hasConceptScore W4231010012C2781187634 @default.
• W4231010012 hasConceptScore W4231010012C30481170 @default.
• W4231010012 hasConceptScore W4231010012C45091340 @default.
• W4231010012 hasConceptScore W4231010012C501734568 @default.
• W4231010012 hasConceptScore W4231010012C502942594 @default.
• W4231010012 hasConceptScore W4231010012C53226629 @default.
• W4231010012 hasConceptScore W4231010012C54355233 @default.
• W4231010012 hasConceptScore W4231010012C59701697 @default.
• W4231010012 hasConceptScore W4231010012C71924100 @default.
• W4231010012 hasConceptScore W4231010012C86803240 @default.
• W4231010012 hasIssue "21" @default.
• W4231010012 hasLocation W42310100121 @default.
• W4231010012 hasOpenAccess W4231010012 @default.
• W4231010012 hasPrimaryLocation W42310100121 @default.
• W4231010012 hasRelatedWork W10962344 @default.
• W4231010012 hasRelatedWork W16103346 @default.
• W4231010012 hasRelatedWork W16910600 @default.
• W4231010012 hasRelatedWork W20203658 @default.
• W4231010012 hasRelatedWork W20479291 @default.
• W4231010012 hasRelatedWork W20866243 @default.
• W4231010012 hasRelatedWork W22328419 @default.
• W4231010012 hasRelatedWork W23194743 @default.
• W4231010012 hasRelatedWork W3093886 @default.
• W4231010012 hasRelatedWork W9490139 @default.
• W4231010012 hasVolume "120" @default.
• W4231010012 isParatext "false" @default.
• W4231010012 isRetracted "false" @default.
• W4231010012 workType "article" @default.